The Moffitt requests $248,588 in annual direct costs for support of Administration personnel, totaling 2.10 FTE. The budget request represents less than 4% of the total CCSG request and is less than 1% of Moffitt's total Research Administration operational budget. Since all research activities at Moffitt are cancer-related, support of research is in direct support of the Cancer Center Support Grant and is composed of three primary functions: Program Administration, Shared Resource Oversight, and Research Administration. Program administrative support is provided at the division level (Basic Science, Prevention &Control, Translational Science, and Clinical Investigations) with dedicated staff led by a Division Administrator who provides support for the programs and faculty within their division. Shared Resource Oversight occurs through alignment and allocation of functions to specific administrative groups: Laboratory Operations;Clinical Trials Office;Tissue;and Cell Therapies. Research Administration represents a collection of Offices that provide a range of support activities including: Institutional Support Services;Sponsored Research;Grant and Contract Accounting;Research Costs Analysis;Clinical Trials Finance;Protocol Review and Support;and Institutional Regulatory Affairs. The administration of research activities for the Cancer Center is organized under Michael Benedict, PharmD, who reports to Dr. Dalton through the Director of the Moffitt Research Institute (MRI) and Associate Center Director for Cancer Prevention and Control, Dr. Sellers. In addition to reporting to the Director of the MRI, Dr. Benedict has functional responsibilities to all Associate Center Directors. Leadership has changed since the last submission. Dr. Benedict, was recruited back to the Cancer Center to serve as Vice President for Clinical Investigations, and in July 2009, was appointed the sole Vice President for Research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA076292-15
Application #
8495973
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-02-01
Budget End
2014-01-31
Support Year
15
Fiscal Year
2013
Total Cost
$124,599
Indirect Cost
$50,654
Name
H. Lee Moffitt Cancer Center & Research Institute
Department
Type
DUNS #
139301956
City
Tampa
State
FL
Country
United States
Zip Code
33612
Kahen, Elliot John; Brohl, Andrew; Yu, Diana et al. (2018) Neurofibromin level directs RAS pathway signaling and mediates sensitivity to targeted agents in malignant peripheral nerve sheath tumors. Oncotarget 9:22571-22585
Hoffman, Melissa A; Fang, Bin; Haura, Eric B et al. (2018) Comparison of Quantitative Mass Spectrometry Platforms for Monitoring Kinase ATP Probe Uptake in Lung Cancer. J Proteome Res 17:63-75
Puri, Sonam; Hyland, Kelly A; Weiss, Kristine Crowe et al. (2018) Prediction of chemotherapy-induced nausea and vomiting from patient-reported and genetic risk factors. Support Care Cancer 26:2911-2918
Gonzalez, Brian D; Small, Brent J; Cases, Mallory G et al. (2018) Sleep disturbance in men receiving androgen deprivation therapy for prostate cancer: The role of hot flashes and nocturia. Cancer 124:499-506
Eroglu, Zeynep; Zaretsky, Jesse M; Hu-Lieskovan, Siwen et al. (2018) High response rate to PD-1 blockade in desmoplastic melanomas. Nature 553:347-350
Lu, Yingchang; Beeghly-Fadiel, Alicia; Wu, Lang et al. (2018) A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Cancer Res 78:5419-5430
Phadke, Manali; Remsing Rix, Lily L; Smalley, Inna et al. (2018) Dabrafenib inhibits the growth of BRAF-WT cancers through CDK16 and NEK9 inhibition. Mol Oncol 12:74-88
Kasting, Monica L; Christy, Shannon M; Sutton, Steven K et al. (2018) Florida physicians' reported use of AFIX-based strategies for human papillomavirus vaccination. Prev Med 116:143-149
Jiang, Kun; Neill, Kevin; Cowden, Daniel et al. (2018) Expression of CAS/CSE1L, the Cellular Apoptosis Susceptibility Protein, Correlates With Neoplastic Progression in Barrett's Esophagus. Appl Immunohistochem Mol Morphol 26:552-556
Park, Jae H; Rivière, Isabelle; Gonen, Mithat et al. (2018) Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia. N Engl J Med 378:449-459

Showing the most recent 10 out of 1254 publications